5 Works

Development of the eNanoMapper ontology and usability within the nanosafety domain

Linda Rieswijk, Thies Oosterwijk, Janna Hastings, Friederike Ehrhart, Chris Evelo & Egon Willighagen
The FP7 EU-funded eNanoMapper project aims to develop computational solutions to support the challenge of human risk assessment of engineered nanomaterials. These solutions could support the design of new, safe and environment-friendly engineered nanomaterials as well as the assessment of existing materials. One of the focuses of the eNanomapper project is on the development and dissemination of a comprehensive ontology for the nanosafety domain. This ontology aims to encompass all information related to the characterization...

Answering scientific questions with linked European nanosafety data

Egon Willighagen, Micha Rautenberg, Denis Gebele, Linda Rieswijk, Friederike Ehrhart, Jiakang Chang, Georgios Drakakis, Penny Nymark, Pekka Kohonen, Gareth Owen, Haralambos Sarimveis, Christoph Helma & Nina Jeliazkova

The BridgeDb framework

Egon Willighagen, Jonathan Mélius, Brenninkmeijer Christian, Stian Soiland-Reyes, Anwesha Bohler, Martina Kutmon, Andra Waagmeester, Alex Pico, Anders Riutta, Alasdair Gray, Christ Leemans, Colin Batchelor, Ola Spjuth, Nuno Nunes, Chris Evelo & Carole Goble
 
What is BridgeDb? Biological systems consist of many thousands of genes, proteins, and metabolites. Our collective knowledge about these entities is collected in many hundreds of disparate databases, each focusing on particular themes of knowledge or types of experiments. Importantly, to capture this focus, each database uses its own definition of the key entities and have a matching collection of entity identifiers. Linking all these identifiers requires a flexible tool that provides identifier mappings (IDmaps)...

Open PHACTS now offers patent information and interactions from Pathways

Chris Evelo, Egon Willighagen, Nick Lynch, Bryn Williams Jones, Antonis Loizou, Stian Soiland­Reyes, Ryan Miller, Anna Gaulton, George Papadatos, Lee Harland, Carole Goble, Peter Woollard, Gerhard Ecker, Daniela Digles & Stefan Senger
Open PHACTS background and History
Open PHACTS started as an Innovative Medicines Initiative (IMI) project in 2011. The objective was to integrate a wide range of pharmacologically related data into a central resource that is described according to standards of the semantic web community. Central to this unification was the development of an API to allow the project partners to build their own custom applications and work streams. Over the course of the IMI project, the...

The Open PHACTS Discovery Platform from a network biology perspective

Chris Evelo, Egon Willighagen, Nick Lynch, Bryn Williams Jones, Antonis Loizou, Stian Soiland-Reyes, Ryan Miller, Anna Gaulton, George Papadatos, Lee Harland, Carole Goble, Peter Woollard, Gerhard Ecker, Daniela Digles & Stefan Senger
Open PHACTS started as an Innovative Medicines Initiative (IMI) project in 2011. The objective was to integrate a wide range of pharmacologically related data into a central resource that is described according to standards of the semantic web community. Central to this unification was the development of an API to allow the project partners to build their own custom applications and workstreams. Also central to the Open PHACTS Discovery Platform is the development of identity resolution and identity...

Publication Year

  • 2016
    5

Data Centers

  • Faculty of 1000 Research Ltd
    5